| Caption | Figure 1: Stain-free images from HistoIndex’s AI-based digital pathology platform show a reduction of fibrous septa (in green) after treatment. After the images are produced, the platform generates data on the assessment of fibrosis parameters, which are crucial in determining treatment evaluation and modification. |
| Source | HistoIndex |
| Contacts | Ms Cynthia Anne Victor, Corporate Communications & PR, HistoIndex, cynthia.victor@histoindex.com |
| Download | |
| Related Press Releases Links |
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China |